These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 25985623)
1. [The cancer stem cell model in hematological malignancies]. Nitta E; Iwama A Nihon Rinsho; 2015 May; 73(5):733-8. PubMed ID: 25985623 [TBL] [Abstract][Full Text] [Related]
2. Epigenetics of hematopoiesis and hematological malignancies. Hu D; Shilatifard A Genes Dev; 2016 Sep; 30(18):2021-2041. PubMed ID: 27798847 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: A product of clonal evolution? van Niekerk G; Davids LM; Hattingh SM; Engelbrecht AM Int J Cancer; 2017 Mar; 140(5):993-999. PubMed ID: 27676693 [TBL] [Abstract][Full Text] [Related]
4. The DNA methylation landscape of hematological malignancies: an update. Blecua P; Martinez-Verbo L; Esteller M Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054 [TBL] [Abstract][Full Text] [Related]
5. Implications of cancer stem cells in the treatment of cancer. Pan CX; Zhu W; Cheng L Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899 [TBL] [Abstract][Full Text] [Related]
6. To portray clonal evolution in blood cancer, count your stem cells. Lyne AM; Laplane L; Perié L Blood; 2021 Apr; 137(14):1862-1870. PubMed ID: 33512426 [TBL] [Abstract][Full Text] [Related]
7. Die hard: are cancer stem cells the Bruce Willises of tumor biology? Fábián A; Barok M; Vereb G; Szöllosi J Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297 [TBL] [Abstract][Full Text] [Related]
10. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919 [TBL] [Abstract][Full Text] [Related]
11. Exploring the cancer stem cell phenotype with high-throughput screening applications. Wurdak H Future Med Chem; 2012 Jun; 4(10):1229-41. PubMed ID: 22800368 [TBL] [Abstract][Full Text] [Related]
12. The role of chromatin modifiers in normal and malignant hematopoiesis. Butler JS; Dent SY Blood; 2013 Apr; 121(16):3076-84. PubMed ID: 23287864 [TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferases in hematologic malignancies. Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483 [TBL] [Abstract][Full Text] [Related]
14. Role of epigenetic changes in hematological malignancies. Lehmann U; Brakensiek K; Kreipe H Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: lessons from leukemia. Wang JC; Dick JE Trends Cell Biol; 2005 Sep; 15(9):494-501. PubMed ID: 16084092 [TBL] [Abstract][Full Text] [Related]
16. Concise reviews: cancer stem cells: from concept to cure. Matchett KB; Lappin TR Stem Cells; 2014 Oct; 32(10):2563-70. PubMed ID: 25078632 [TBL] [Abstract][Full Text] [Related]
17. Novel epigenetic therapies in hematological malignancies: Current status and beyond. Gallipoli P; Huntly BJP Semin Cancer Biol; 2018 Aug; 51():198-210. PubMed ID: 28782607 [TBL] [Abstract][Full Text] [Related]
18. Revisiting the concept of cancer stem cells in prostate cancer. Wang ZA; Shen MM Oncogene; 2011 Mar; 30(11):1261-71. PubMed ID: 21119602 [TBL] [Abstract][Full Text] [Related]
19. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach. Turner C; Kohandel M J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969 [TBL] [Abstract][Full Text] [Related]
20. The Potential Roles and Advantages of Single Cell Sequencing in the Diagnosis and Treatment of Hematological Malignancies. Shi M; Dong X; Huo L; Wei X; Wang F; Sun K Adv Exp Med Biol; 2018; 1068():119-133. PubMed ID: 29943300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]